Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.79
Delayed Data
As of Apr 29
 -0.25 / -0.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
AssetsCash860.3M1.8B2.3B2.5B
 
 
 
 
 
Short Term Investment Cash-1.2B847.9M558.4M146.2M
 
 
 
 
 
Cash & Short Term Investments1.1B1.8B2.7B3.0B
 
 
 
 
 
 
ReceivablesReceivables3.1B2.9B2.7B3.0B
 
 
 
 
 
 
InventoriesInventories1.8B1.9B1.9B1.9B
 
 
 
 
 
 
Current AssetsPrepaid Expenses------127.9M
 
 
Other Current Assets353.6M451.4M422.9M0.00
 
 
 
 
Current Assets6.2B7.1B7.7B8.0B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------7.4B
 
 
Depreciation-------3.7B
 
 
Intangible Assets197.2M218.1M219.2M314.1M
 
 
 
 
 
Other Assets197.2M218.1M219.2M314.1M
 
 
 
 
 
Total Assets11.1B12.1B12.7B13.4B
 
 
 
 
 
 
LiabilitiesAccounts Payable577.1M587.3M575.3M717.2M
 
 
 
 
 
Short Term Debt85.4M109.9M94.3M156.2M
 
 
 
 
 
Accrued Expenses------850.1M
 
 
Other Current Liabilities4.9B4.6B4.6B3.9B
 
 
 
 
 
Other Liabilities6.0B5.8B5.8B5.9B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-1.0B-992.0M-923.8M-989.8M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
Total Liabilities6.5B6.3B6.3B6.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity4.6B5.8B6.5B6.8B
 
 
 
 
 
Total Shareholder Equity4.6B5.8B6.5B6.8B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.1B2.1B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.